Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4KY4

Crystal structure of non-classical TS inhibitor 2 in complex with Toxoplasma gondii TS-DHFR

Summary for 4KY4
Entry DOI10.2210/pdb4ky4/pdb
Related4EIL 4KYA
DescriptorBifunctional dihydrofolate reductase-thymidylate synthase, 2'-DEOXYURIDINE 5'-MONOPHOSPHATE, Aminopterin, ... (5 entities in total)
Functional Keywordssynthase, bifunctional, oxidoreductase, transferase
Biological sourceToxoplasma gondii
Total number of polymer chains8
Total formula weight565160.24
Authors
Sharma, H.,Anderson, K.S. (deposition date: 2013-05-28, release date: 2014-08-06, Last modification date: 2023-09-20)
Primary citationZaware, N.,Sharma, H.,Yang, J.,Devambatla, R.K.,Queener, S.F.,Anderson, K.S.,Gangjee, A.
Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections.
ACS Med Chem Lett, 4:1148-1151, 2013
Cited by
PubMed Abstract: Infection by the parasite (tg) can lead to toxoplasmosis in immunocompromised patients such as organ transplant, cancer and HIV/AIDS patients. The bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) enzyme is crucial for nucleotide synthesis in , and represents a potential target to combat infection. While species selectivity with drugs has been attained for DHFR, TS is much more conserved across species and specificity is significantly more challenging. We discovered novel substituted-9-pyrimido[4,5-]indoles - with single-digit nanomolar K for tgTS, two of which, and , are 28- and 122-fold selective over human TS (hTS). The synthesis of these compounds, and their structures in complex with tgTS-DHFR are presented along with binding measurements and cell culture data. These results show, for the very first time, that in spite of the high degree of conservation of active site residues between hTS and the parasite TS, specificity has been accomplished via novel structures and provides a new target (TS) for selective drug development against parasitic infections.
PubMed: 24470841
DOI: 10.1021/ml400208v
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.79 Å)
Structure validation

235458

PDB entries from 2025-04-30

PDB statisticsPDBj update infoContact PDBjnumon